Yfat Kadan, MD, has been named assistant professor in the Department of Obstetrics and Gynecology. She will see patients at Lattimore Medical Center as well as Highland Hospital. Most recently, she served as a faculty member in the Department of Gynecologic Oncology at Chaim Sheba Medical Center at Tel Aviv University in Israel. She has also worked as a clinical lecturer at Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology and as a clinical instructor at Sackler School of Medicine at Tel-Aviv University in Israel. She completed her fellowship in Gynecologic Oncology at the Women & Infants Hospital of Rhode Island and trained in radical gynecologic oncologic surgeries with the Metropolitan Gynecologic Oncologic team in Budapest, Hungary. She completed her residency in Obstetrics and Gynecology at HaEmek Medical Center and earned her medical degree from Ben-Gurion University (of the Negev), Beer-Sheva, Israel. She has many years of experience teaching medical students and residents and has taught post-graduate and professional courses.

Languages

English, Hebrew

Faculty Appointments

Assistant Professor - Department of Obstetrics and Gynecology (SMD)

Credentials

Residency & Fellowship

Fellowship, Gynecologic Oncology, Women and Infants Hospital of Rhode Island. 2012 - 2014

Residency, Obstetrics & Gynecology, HaEmek Medical Center (Israel). 2004 - 2011

Education

MD | Ben Gurion University (Israel). Obstetrics & Gynecology, Reproductive Endocrinology. 2004

Publications

Journal Articles

Bilateral or unilateral tubo-ovarian abscess: exploring its clinical significance.

Yagur Y, Weitzner O, Shams R, Man-El G, Kadan Y, Daykan Y, Klein Z, Schonman R

BMC women's health.. 2023 December 1923 (1):678. Epub 12/19/2023.

Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis.

Nahshon C, Kadan Y, Lavie O, Ostrovsky L, Segev Y

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2023 October 233 (10):1557-1563. Epub 10/02/2023.

Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O

Cancer letters.. 2023 June 1563 :216196. Epub 04/25/2023.

Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.

Bahar-Shany K, Barnabas GD, Deutsch L, Deutsch N, Glick-Saar E, Dominissini D, Sapoznik S, Helpman L, Perri T, Blecher A, Katz G, Yagel I, Rosenblatt O, Shai D, Brandt B, Meyer R, Mohr-Sasson A, Volodarsky-Perel A, Zilberman I, Armon S, Jakobson-Setton A, Eitan R, Kadan Y, Beiner M, Josephy D, Brodsky M, Friedman E, Anafi L, Molchanov Y, Korach J, Geiger T, Levanon K

International journal of cancer.. 2023 February 15152 (4):781-793. Epub 10/23/2022.

Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy.

Weitzner O, Yagur Y, Kadan Y, Fishman A, Zissin R, Ben-Ezry E, Helpman L, Beiner ME

BMC women's health.. 2022 December 1922 (1):531. Epub 12/19/2022.

Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer.

Yfat K, Mariam K, Mario B, Hal H, Dana J, Lina S, Ilan B, Gregory P, Limor H

Gynecologic oncology.. 2022 November 167 (2):256-260. Epub 09/23/2022.

Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers.

Kadan Y, Baron A, Brezinov Y, Ben Arie A, Fishman A, Beiner M

Gynecologic oncology reports.. 2022 February 39 :100917. Epub 12/26/2021.

High grade, advanced, serous ovarian cancer with low serum CA125 levels.

Asali A, Haj-Yehia N, Zehavi T, Perry T, Beiner M, Fishman A, Kadan Y

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.. 2021 October 41 (7):1107-1111. Epub 01/11/2021.

DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O

Cancer letters.. 2021 March 31501 :224-233. Epub 11/19/2020.

Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study.

Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, Leytes S, Lavie O, Ben-Arie A, Amit A, Namazov A, Volodarsky M, Ben-Shachar I, Atlas I, Bruchim I, Kadan Y, Helpman L

Acta obstetricia et gynecologica Scandinavica.. 2021 March 100 (3):444-452. Epub 10/30/2020.

Time interval from biopsy to surgery and risk for adjuvant therapy in patients with low-risk endometrial cancer.

Kadan Y, Asali A, Fishman A, Helpman L, Perri T, Korach J, Beiner M

Surgical oncology.. 2020 December 35 :1-4. Epub 07/25/2020.

The identification of nuclear ?v?3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions.

Seraya-Bareket C, Weisz A, Shinderman-Maman E, Teper-Roth S, Stamler D, Arbib N, Kadan Y, Fishman A, Kidron D, Edelstein E, Ellis M, Ashur-Fabian O

Oncogenesis.. 2020 July 299 (7):69. Epub 07/29/2020.

Ethnic Disparities for Gynecologic Cancers in Israel.

Kadan Y, Fishman A, Helpman L

Journal of racial and ethnic health disparities.. 2020 June 7 (3):421-427. Epub 11/25/2019.

Chemotherapy Toxicity in Mutation Carriers Undergoing First-Line Platinum-Based Chemotherapy.

Weitzner O, Yagur Y, Kadan Y, Beiner ME, Fishman A, Ben Ezry E, Amitai Komem D, Helpman L

The oncologist.. 2019 December 24 (12):e1471-e1475. Epub 07/25/2019.

Conservative management for postmenopausal women with tubo-ovarian abscess.

Yagur Y, Weitzner O, Man-El G, Schonman R, Klein Z, Fishman A, Beiner M, Kadan Y

Menopause : the journal of the North American Menopause Society.. 2019 July 26 (7):793-796. Epub 1900 01 01.

Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.

Barnabas GD, Bahar-Shany K, Sapoznik S, Helpman L, Kadan Y, Beiner M, Weitzner O, Arbib N, Korach J, Perri T, Katz G, Blecher A, Brandt B, Friedman E, Stockheim D, Jakobson-Setton A, Eitan R, Armon S, Brand H, Zadok O, Aviel-Ronen S, Harel M, Geiger T, Levanon K

Molecular & cellular proteomics : MCP.. 2019 May 18 (5):865-875. Epub 02/13/2019.

Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.

Helpman L, Perri T, Lavee N, Hag-Yahia N, Chariski HA, Kalfon S, Derazne E, Beiner ME, Kadan Y, Fishman A, Korach J, Covens A, Gien L

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2019 January 29 (1):133-139. Epub 1900 01 01.

Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.

Yagur Y, Weitzner O, Gemer O, Lavie O, Beller U, Bruchim I, Vaknin Z, Levy T, Rabinovich A, Shachar IB, Meirovitz A, Arie AB, Derazne E, Raban O, Eitan R, Kadan Y, Fishman A, Helpman L

Gynecologic oncology.. 2018 August 150 (2):288-292. Epub 05/26/2018.

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.

Kadan Y, Raviv O, Segev Y, Lavie O, Bruchim I, Fishman A, Michaelson R, Beller U, Helpman L

International journal of gynaecology and obstetrics : the official organ of the International Federation of Gynaecology and Obstetrics.. 2018 July 142 (1):91-96. Epub 04/02/2018.

Predictors for lymph nodes involvement in low risk endometrial cancer.

Kadan Y, Calvino AS, Katz A, Katz S, Moore RG

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.. 2017 May 37 (4):514-518. Epub 03/24/2017.

Predictive factors for the presence of malignant transformation of pelvic endometriosis.

Kadan Y, Fiascone S, McCourt C, Raker C, Granai CO, Steinhoff M, Moore RG

European journal of obstetrics, gynecology, and reproductive biology.. 2015 February 185 :23-7. Epub 12/02/2014.

Comparison between amniotomy, oxytocin or both for augmentation of labor in prolonged latent phase: a randomized controlled trial.

Nachum Z, Garmi G, Kadan Y, Zafran N, Shalev E, Salim R

Reproductive biology and endocrinology : RB&E.. 2010 November 78 :136. Epub 11/07/2010.

Abdominal scar characteristics as a predictor of intra-abdominal adhesions at repeat cesarean delivery.

Salim R, Kadan Y, Nachum Z, Edelstein S, Shalev E

Fertility and sterility.. 2008 December 90 (6):2324-7. Epub 01/07/2008.

Rudimentary horn pregnancy diagnosed by ultrasound and treated by laparoscopy--a case report and review of the literature.

Kadan Y, Romano S

Journal of minimally invasive gynecology.. 2008 15 (5):527-30. Epub 07/10/2008.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.